Endoscopic vacuum therapy in walled-off necrosis of the pancreas: a multicenter cohort study.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024980

Enrollment

Registered

2021-05-03

Start date

2021-05-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K85

Interventions

Group 1: WON treated with EVT (intial vacuum therapy via a transmural endoscopic access). Group 2: WON in similar severity, treated with center standard.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with walled-off pancreatic necrosis in need of intervention.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

Measure	Time frame
severe complations or death regardless of cause	—

Secondary

Measure	Time frame
- probable or possible severe complication or death associated with EVT - probable or possible mild complication associated with EVT - surgical or percutaneous step-up - clinical success - technical success - radiological success - sustained success in follow up (at least 2 month after discharge) - course of infection under EVT (CRP, PCT, WBC) - duration of therapy - quality of life after therapy	—

Countries

Germany

Contacts

Public ContactJakob Garbe

Klinik für Innere Medizin IUniversitätsklinikum Halle

jakob.garbe@uk-halle.de0345 557 2928

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026